LOS ANGELES--(BUSINESS WIRE)--CompuMed, Inc. (OTCBB:CMPD) -- a medical informatics company leading the development of advanced imaging technology for cost effective analysis and monitoring – today released the following letter to shareholders by CompuMed CEO Jerry McLaughlin, in conjunction with his presentation at the Rodman & Renshaw Conference.
